20 May 2025As the U.S. introduces sweeping tariff reforms and redefines global trade dynamics, Aldous Mitchell, Partner at Candesic, highlights how these…
2 May 2025Dr Leonid Shapiro, Managing Partner at Candesic, shares insights with Healthcare Business International on Fremman Capital’s acquisition of Amethyst Healthcare…- 1 November 2024Global private equity healthcare specialist ARCHIMED has acquired FIM Medical, a leader in the vision, audio & respiratory medical devices…
- 16 July 2024As the number and complexity of clinical trials rises, participants are an increasingly precious resource.In an online piece for PharmaTimes,…
- 29 May 2024NICE (National Institute for Health and Care Excellence) has set out its proposals for moving towards a more integrated, rules-based…
- 21 May 2024The latest interview in our regular "Candesic in conversation with" series sees us chatting with Tim Clover, CEO of UK-based ophthalmology medical…
- 22 April 2024As fans of numerous science fiction series know (Matrix, Terminator, et al. we are looking at you), before too long…
15 January 2024Dr Michelle Tempest, Senior Partner at Candesic, is the co-author of "The Brain Economy: Advancing Brain Science to Better Understand the Modern…- 21 December 2023What is in store for healthtech investment in 2024? Candesic Senior Partner Dr Michelle Tempest shares her views with HealthInvestor. Beyond the expectation of further…
- 15 September 2023We are thrilled to announce Candesic Senior Partner Dr Michelle Tempest, continues to drive the exciting brain capital initiative with…
